名稱 | CEBPA p.E59Q Reference Standard 標(biāo)準(zhǔn)品 |
型號(hào) | CBP10539 |
報(bào)價(jià) | |
特點(diǎn) | CEBPA p.E59Q Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- 如何正確的進(jìn)行ELISA試劑盒的操作
- 選擇進(jìn)口的細(xì)胞株這幾點(diǎn)千萬不能忘!
- 【靶點(diǎn)模型+診斷質(zhì)控】BCR-ABL1的藥物開發(fā)和診斷
- 【連載-企業(yè)參考品】胃腸道間質(zhì)瘤的PCR和NGS參考品的選擇
- 羅氏乳腺癌新藥獲英國(guó)NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- 腫瘤免疫藥靶細(xì)胞模型系列——LAG3
- 4-1BB(CD137)靶點(diǎn)藥物篩選模型
- 攝入全谷類食物能明顯降低患結(jié)直腸癌的風(fēng)險(xiǎn)
- 實(shí)驗(yàn)?zāi)芊裰貜?fù)仍在持續(xù):誰來給韓春雨事件畫上句號(hào)?
- 非小細(xì)胞肺癌免疫治療 先放療更有效
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10539CEBPA p.E59Q Reference Standard 標(biāo)準(zhǔn)品
- 詳細(xì)內(nèi)容
CBP10539 | |
Format | Genomic DNA |
Description | CEBPA, CCAAT enhancer binding protein alpha, is a transcription factor that regulates the expression of genes involved in cell differentiation (PMID: 26601784). Inactivation of CEBPA is associated with the pathogenesis of leukemia, including biallelic CEBPA-mutant AML (PMID: 32086816), and dysregulation of CEBPA has been identified in various solid tumors (PMID: 28720765, PMID: 28504718). |
Technical Data | |
DNA Change | c.175G>C |
AA Change | p.E59Q |
Mutation type | Missense_Mutation |
Zygosity | Heterozygous |
Allelic Frequency | N/A |
Transcript | NM_004364.5 |
Cosmic ID | N/A |
Chr position(GRCh37) | chr19:33793146 |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |